
Work Here?
AMBOSS provides a medical knowledge platform used by students and clinicians. It combines an interactive library and high-yield question bank for students to study and prep for exams with a clinical decision support system for clinicians to guide patient care using evidence-based recommendations. The platform works online: users search and study from the medical library, practice with questions, and access point-of-care guidance and clinical decision support at the bedside or in clinics. AMBOSS differentiates itself through its physician-founded approach, a global team of physicians, scientists, and engineers, and its breadth of content that serves over a million healthcare professionals in 180+ countries, integrating both learning tools and real-time clinical guidance in one platform. The company aims to improve medical knowledge and clinical decision-making worldwide, helping physicians provide better patient care.
Industries
Data & Analytics
Enterprise Software
Education
Healthcare
Company Size
1,001-5,000
Company Stage
Late Stage VC
Total Funding
$302M
Headquarters
Berlin, Germany
Founded
2012
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$301.9M
Above
Industry Average
Funded Over
3 Rounds
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Mental Health Support
Flexible Work Hours
Remote Work Options
Relocation Assistance
STARTUPLAND is set for November 5 at Cologne's RheinEnergieStadion, featuring talks, pitches, and networking. Key speakers include Sievert Weiss of Amboss, which raised €240 million at an €800 million valuation, and Shikha Ahluwalia from Balderton Capital, focusing on mental health. Sven Lackinger of Sastrify will discuss challenges in scaling. The event includes a pitch stage for young startups and is part of the RISE in STARTUPLAND-Week, turning Cologne into a startup hub.
BPI has invested in AMBOSS, a platform evolving from a medical student tool to an AI-supported clinical companion for healthcare professionals. With over 1 million users globally, AMBOSS is expanding in the US and DACH regions. The company operates a hybrid B2C/B2B model, showing strong growth and profitability. AMBOSS is also expanding into new markets and roles, leveraging AI for reliable clinical decision-making. The investment supports AMBOSS's mission to enhance healthcare outcomes.
Amboss, a medical learning platform, is aiming to become a market leader by raising significant funds, more than most healthtech startups. The new capital will also be used for acquisitions, with a key focus on expanding in the USA.
In Q1 2025, over €2.5 billion was invested in more than 40 startups. Notable investments include Finn, Amboss, and Solaris. Finn received up to €1 billion from Citi, Jefferies, and Avellinia Capital. Amboss secured €240 million from Kirkbi, M&G Investments, Lightrock, and existing investors, valuing the company at €800 million. Solaris attracted investment from SBI Group and Boerse Stuttgart Group.
Amboss has raised €240 million in a funding round led by Kirkbi, MG Investments, and Lightrock, with existing investors also participating. The Berlin-based EdTech company is now valued at approximately €800 million. The new capital will be used to expand into international markets and enhance offerings for healthcare professionals.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
Education
Healthcare
Company Size
1,001-5,000
Company Stage
Late Stage VC
Total Funding
$302M
Headquarters
Berlin, Germany
Founded
2012
Find jobs on Simplify and start your career today